OliX Pharmaceuticals올릭스

OliX Pharmaceuticals226950· Biotech & PharmaInitiation

OliX Pharmaceuticals: Persistent Losses and a High Sales Multiple Behind a ₩2.1T Market Value

OliX, a KOSDAQ-listed biotech, closed at ₩106,200 on 2026-10-12 for a market value of about ₩2.1T, while trailing revenue of ₩13.6B came with an operating loss of ₩41.6B. The shares are down 16.7% over three months but up 10.3% over one year, and our model could not produce a fair value range.

Oct 13, 20260 views